# Associations between carotid artery intima-media thickness, traditional risk factors and proteins

**Authors:** Lars Lind, Rui Zheng

PMC · DOI: 10.1038/s44325-025-00073-7 · npj Cardiovascular Health · 2025-07-02

## TL;DR

This study explores how traditional risk factors and proteins are linked to carotid artery thickness, identifying potential new targets for cardiovascular disease.

## Contribution

The study identifies RABEPK as a potential therapeutic target for cardiovascular disease through causal analysis.

## Key findings

- LDL-cholesterol, BMI, diabetes, and systolic blood pressure are causally linked to increased carotid IMT.
- RABEPK is associated with IMT and shows concordant directional relationships in Mendelian randomization analysis.
- 17 out of 63 proteins linked to IMT were externally replicated, with five confirmed through MR.

## Abstract

We aimed to assess the role of traditional cardiovascular risk factors on carotid artery intima-media thickness (IMT) and proteins associated with IMT. IMT was measured in 50,704 participants from the UK Biobank. Plasma levels of 2923 proteins were analyzed in 6328 individuals. Mendelian randomization (MR) analyses used genetic data on IMT, proteins, and risk factors. Observational analyses showed positive associations of LDL-cholesterol, body mass index (BMI), diabetes, and systolic blood pressure (SBP) with IMT, while HDL-cholesterol was inversely related. MR analysis confirmed causality for LDL, BMI, diabetes, but not HDL. Of 63 proteins observationally linked to IMT, 17 were replicated externally. Five proteins (BCAM, NTproBNP/NPPB, RABEPK, ACAN, FN1) were associated with IMT in MR, with RABEPK showing concordant directional relationships. MR supports causal links between LDL, BMI, diabetes, SBP, and IMT. RABEPK emerged as a potential therapeutic target, warranting further investigation.

## Linked entities

- **Genes:** RABEPK (Rab9 effector protein with kelch motifs) [NCBI Gene 10244], NPPB (natriuretic peptide B) [NCBI Gene 4879], BCAM (basal cell adhesion molecule (Lutheran blood group)) [NCBI Gene 4059], ACAN (aggrecan) [NCBI Gene 176], FN1 (fibronectin 1) [NCBI Gene 2335]
- **Proteins:** BCAM (basal cell adhesion molecule (Lutheran blood group)), RABEPK (Rab9 effector protein with kelch motifs), ACAN (aggrecan), FN1 (fibronectin 1)
- **Diseases:** diabetes (MONDO:0005015)

## Full-text entities

- **Genes:** IGKV5-2 (immunoglobulin kappa variable 5-2) [NCBI Gene 28907] {aka B2, IGKV52}, HAVCR1 (hepatitis A virus cellular receptor 1) [NCBI Gene 26762] {aka CD365, HAVCR, HAVCR-1, KIM-1, KIM1, TIM}, FAP (fibroblast activation protein alpha) [NCBI Gene 2191] {aka DPPIV, FAPA, FAPalpha, SIMP}, CLMP (CXADR like cell adhesion molecule) [NCBI Gene 79827] {aka ACAM, ASAM, CSBM, CSBS}, FDX1 (ferredoxin 1) [NCBI Gene 2230] {aka ADX, FDX, LOH11CR1D}, FGFR4 (fibroblast growth factor receptor 4) [NCBI Gene 2264] {aka CD334, JTK2, TKF}, PRELP (proline and arginine rich end leucine rich repeat protein) [NCBI Gene 5549] {aka MST161, MSTP161, SLRR2A}, NPPB (natriuretic peptide B) [NCBI Gene 4879] {aka BNP, Iso-ANP}, POLE4 (DNA polymerase epsilon 4, accessory subunit) [NCBI Gene 56655] {aka YHHQ1, p12}, FABP4 (fatty acid binding protein 4) [NCBI Gene 2167] {aka A-FABP, AFABP, ALBP, HEL-S-104, aP2}, CHGB (chromogranin B) [NCBI Gene 1114] {aka SCG1}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, NCAN (neurocan) [NCBI Gene 1463] {aka CSPG3}, DSG4 (desmoglein 4) [NCBI Gene 147409] {aka CDGF13, CDHF13, HYPT6, LAH}, PON3 (paraoxonase 3) [NCBI Gene 5446], RAB9A (RAB9A, member RAS oncogene family) [NCBI Gene 9367] {aka RAB9}, SMOC2 (SPARC related modular calcium binding 2) [NCBI Gene 64094] {aka DTDP1, DTDP1A, MST117, MSTP117, MSTP140, SMAP2}, BCAM (basal cell adhesion molecule (Lutheran blood group)) [NCBI Gene 4059] {aka AU, B-CAM, CD239, F8/G253, LU, MSK19}, SPINT3 (serine peptidase inhibitor, Kunitz type 3) [NCBI Gene 10816] {aka HKIB9}, IGFBP1 (insulin like growth factor binding protein 1) [NCBI Gene 3484] {aka AFBP, IBP1, IGF-BP25, PP12, hIGFBP-1}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, TOR1AIP1 (torsin 1A interacting protein 1) [NCBI Gene 26092] {aka LAP1, LAP1B, LAP1C, LGMD2Y}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, ATF4 (activating transcription factor 4) [NCBI Gene 468] {aka CREB-2, CREB2, TAXREB67, TXREB}, PREP (prolyl endopeptidase) [NCBI Gene 5550] {aka PE, PEP}, RABEPK (Rab9 effector protein with kelch motifs) [NCBI Gene 10244] {aka RAB9P40, bA65N13.1, p40}, ACAN (aggrecan) [NCBI Gene 176] {aka AGC1, AGCAN, CSPG1, CSPGCP, MSK16, SEDK}, CST6 (cystatin E/M) [NCBI Gene 1474] {aka ECTD15}, GAL (galanin and GMAP prepropeptide) [NCBI Gene 51083] {aka ETL8, GAL-GMAP, GALN, GLNN, GMAP}, TACSTD2 (tumor associated calcium signal transducer 2) [NCBI Gene 4070] {aka EGP-1, EGP1, GA733-1, GA7331, GP50, M1S1}
- **Diseases:** myocardial disorders (MESH:D009202), stroke (MESH:D020521), BMI (MESH:C536030), IMT (MESH:D010033), CHD (MESH:D003327), Alzheimer s disease (MESH:D000544), polycytemia vera (MESH:D011087), drug abuse (MESH:D019966), cancer (MESH:D009369), diabetes (MESH:D003920), vascular diseases (MESH:D014652), T2D (MESH:D003924), bipolar disorders (MESH:D001714), sickle-cell anemia (MESH:D000755), retinal-vein occlusion (MESH:D012170), vitreomacular adhesion (MESH:D000267), hypertension (MESH:D006973), atherosclerosis (MESH:D050197), infections (MESH:D007239), myocardial infarction (MESH:D009203), ischemic stroke (MESH:D002544), thickened IMT (MESH:D013585), MR (MESH:C562757)
- **Chemicals:** cholesterol (MESH:D002784), hyaluronan (MESH:D006820), lipids (MESH:D008055), Ocriplasmin (MESH:C054561), glucose (MESH:D005947), creatinine (MESH:D003404), blood lipid (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** PP.H4 — Homo sapiens (Human), Multifocal osteosarcoma, Cancer cell line (CVCL_6E83)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12912406/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12912406/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12912406/full.md

---
Source: https://tomesphere.com/paper/PMC12912406